Hemolytic Disease of the Fetus and Newborn due to Intravenous Drug Use

Abstract

Objectives The objective is to present a pregnancy complication associated with intravenous drug use, namely, that of red blood cell alloimmunization and hemolytic disease of the fetus and newborn.

Methods An observational case series is presented including women with red blood cell alloimmunization most likely secondary to intravenous drug abuse

Results Five pregnancies were identified that were complicated by red blood cell alloimmunization and significant hemolytic disease of the fetus and newborn, necessitating intrauterine transfusion, an indicated preterm birth, or neonatal therapy.

Conclusions As opioid abuse continues to increase in the United States, clinicians should be aware of the potential for alloimmunization to red blood cell antibodies as yet another negative outcome from intravenous drug abuse.

Keywords

hemolytic disease - fetus - newborn - red blood cell - alloimmunization - intravenous drug use - opiate abuse

• References

• 1 Rudd RA, Paulozzi LJ, Bauer MJ , et al; Centers for Disease Control and Prevention (CDC). Increases in heroin overdose deaths - 28 states, 2010 to 2012. MMWR Morb Mortal Wkly Rep 2014; 63 (39) 849-854
• 2 Substance Abuse and Mental Health Services Administration. Results from the 2010 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-41, HHS Publication No. (SMA) 11–4658. Rockville, MD: SAHMSA; 2011
• 3 Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-48, HHS Publication No. (SMA) 14–4863. Rockville, MD: SAHMSA; 2014
• 4 Patrick SW, Schumacher RE, Benneyworth BD, Krans EE, McAllister JM, Davis MM. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012; 307 (18) 1934-1940
• 5 Whiteman VE, Salemi JL, Mogos MF, Cain MA, Aliyu MH, Salihu HM. Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States. J Pregnancy 2014; 2014: 906723
• 6 Fong MK, Grossman BJ, Hillyer C, Westhoff CM ; American Association of Blood Banks. Technical Manual of the American Association of Blood Banks . 18th ed, 2014
• 7 Bowman J, Harman C, Manning F, Menticoglou S, Pollock J. Intravenous drug abuse causes Rh immunization. Vox Sang 1991; 61 (2) 96-98
• 8 Klein HG, Anstee DJ eds. The Rh blood group system (including LW and RHAG). In: Mollison's Blood Transfusion in Clinical Medicine. 12th ed. Oxford, UK: John Wiley & Sons; 2014: 167-213
• 9 Bowman JM. The prevention of Rh immunization. Transfus Med Rev 1988; 2 (3) 129-150
• 10 Tassiopoulos K, Bernstein J, Bernstein E. Age and sharing of needle injection equipment in a cohort of Massachusetts injection drug users: an observational study. Addict Sci Clin Pract 2013; 8: 20-28
• 11 Giorlandino C, Bilancioni E, D'Alessio P, Muzii L. Risk of iatrogenic fetal infection at prenatal diagnosis. Lancet 1994; 343 (8902) 922-923
• 12 Minola E, Maccabruni A, Pacati I, Martinetti M. Amniocentesis as a possible risk factor for mother-to-infant transmission of hepatitis C virus. Hepatology 2001; 33 (5) 1341-1342